Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

450 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Seom guidelines for the treatment of gastric cancer 2015.
Martin-Richard M, Custodio A, García-Girón C, Grávalos C, Gomez C, Jimenez-Fonseca P, Manzano JL, Pericay C, Rivera F, Carrato A. Martin-Richard M, et al. Clin Transl Oncol. 2015 Dec;17(12):996-1004. doi: 10.1007/s12094-015-1456-y. Epub 2015 Dec 21. Clin Transl Oncol. 2015. PMID: 26691658 Free PMC article.
Second-line systemic therapy for metastatic colorectal cancer.
Mocellin S, Baretta Z, Roqué I Figuls M, Solà I, Martin-Richard M, Hallum S, Bonfill Cosp X. Mocellin S, et al. Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD006875. doi: 10.1002/14651858.CD006875.pub3. Cochrane Database Syst Rev. 2017. PMID: 28128439 Free PMC article. Review.
Clinical Impact of Circulating Tumor RAS and BRAF Mutation Dynamics in Patients With Metastatic Colorectal Cancer Treated With First-Line Chemotherapy Plus Anti-Epidermal Growth Factor Receptor Therapy.
Maurel J, Alonso V, Escudero P, Fernández-Martos C, Salud A, Méndez M, Gallego J, Rodriguez JR, Martín-Richard M, Fernández-Plana J, Manzano H, Méndez JC, Zanui M, Falcó E, Gil-Raga M, Aparicio J, Feliu J, García-Albéniz X, Torres F, Rojo F, Bellosillo B, Mendiola M, Fernández V, Reig O, Claes B, Maertens G, Sablon E, Jacobs B, Montagut C. Maurel J, et al. JCO Precis Oncol. 2019 Dec;3:1-16. doi: 10.1200/PO.18.00289. JCO Precis Oncol. 2019. PMID: 35100697
Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial.
Pelegrí A, Calvo L, Antón A, Mayordomo JI, Florián J, Vásquez S, Arcusa A, Martín-Richard M, Bayo JL, Carrasco E, Virizuela J; Spanish Group for Breast Cancer Research (GEICAM). Pelegrí A, et al. Clin Breast Cancer. 2005 Dec;6(5):433-8. doi: 10.3816/cbc.2005.n.048. Clin Breast Cancer. 2005. PMID: 16381627 Clinical Trial.
450 results